Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 16, 1991
Issued Date -
N/A
app pub date -
Apr 17, 1990
filing date -
Apr 8, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The presence and location of amyloid deposits in an organ or body area of a patient is effected by intravenous administration of novel radioactive iodine-labeled amyloid binding compounds and preferably .sup.123 I-labeled compounds to the patient and sensing radiation emitted from the organ or body area. Novel non-radioactive iodine substituted amyloid binding compounds and amyloid binding compounds which are readily iodinated are further aspects or the invention.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully